Global Endocrine Testing Industry Outlook 2025-2029: Market Set to Cross $3.89 Billion Milestone

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Endocrine Testing Market Size By 2025?
Strong expansion has characterized the endocrine testing market recently, projecting an increase from its 2024 valuation of $2.55 billion to $2.79 billion by 2025, reflecting a compound annual growth rate (CAGR) of 9.6%; this upward trajectory during the past period owes its momentum to the identification of hormones and endocrine systems, the establishment of consistent diagnostic testing procedures, proactive public health campaigns, and greater patient awareness coupled with self-advocacy.

How Big Is the Endocrine Testing Market Size Expected to Grow by 2029?
Significant expansion is projected for the endocrine testing market over the approaching years, with its value anticipated to reach $3.89 billion by 2029, reflecting a compound annual growth rate (CAGR) of 8.7% throughout this projection timeframe; this upward trajectory is primarily driven by the rising incidence of endocrine-related ailments, greater expenditures in defense sectors, the demographic shift towards an older population, heightened understanding and earlier disease identification, alongside burgeoning general awareness. Key developments anticipated to shape this market throughout the forecast include progress in identifying specific biomarkers, the incorporation of omics technologies, the adoption of artificial intelligence and machine learning methodologies, efforts toward establishing unified quality assurance and standardization protocols, and a greater focus on cooperative research initiatives and translational medical applications.

View the full report here:
https://www.thebusinessresearchcompany.com/report/endocrine-testing-global-market-report

Which Key Market Drivers Powering Endocrine Testing Market Expansion and Growth?
The escalating incidence of diabetes is anticipated to fuel the expansion of the endocrine testing sector in the future; diabetes, characterized by elevated blood glucose concentrations, is becoming more widespread due to elements like poor dietary habits, inactive living patterns, inherited tendencies, and an older demographic structure. Diagnostic tools within this segment-such as tests for hemoglobin A1c, fasting plasma glucose, and C-peptide-are essential for identifying diabetes, tracking glucose control, and evaluating the body's insulin function, illustrated by the concerning surge reported by the UK's National Health Service in June 2024, where the count for people under forty climbed from 173,166 in 2022 to 216,440 in 2023, powerfully demonstrating the faster progression of diabetic cases among younger demographics, thus making the increased frequency of diabetes a direct catalyst for the growth observed in the endocrine testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15562&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Endocrine Testing Market?
Leading firms within the endocrine analysis sector are focusing efforts on creating testing methods accessible at the point of care, aiming to boost both the ease of use and speed in diagnosing ailments related to the endocrine system. These near-patient testing options provide swift feedback, which is instrumental for the prompt identification and handling of heart failure in individuals experiencing symptoms like breathlessness and weariness. To illustrate, in the fourth month of 2024, the Swiss pharmaceutical giant Roche Holding AG introduced an NT-proBNP test designed for point-of-care use in India, targeting the screening of diabetic individuals susceptible to cardiovascular conditions like heart failure (HF). This diagnostic tool promotes swifter identification and prompt action, empowering healthcare providers to pinpoint Type 2 Diabetes Mellitus (T2D) patients carrying elevated risk factors and commence essential dialogue regarding treatment without delay, consequently leading to better patient prognoses and overall health.

What Are the Emerging Segments in the Endocrine Testing Market?
The endocrine testingmarket covered in this report is segmented -

1) By Test Type: Estradiol (E2) Test; Follicle Stimulating Hormone (FSH) Test; Human Chorionic Gonadotropin (hCG) Hormone Test; Luteinizing Hormone (LH) Test; Dehydroepiandrosterone Sulfate (DHEAS) Test; Progesterone Test; Testosterone Test; Thyroid Stimulating Hormone (TSH) Test; Prolactin Test; Other Types
2) By Technology: Tandem Mass Spectrometry; Immunoassay; Monoclonal And Polyclonal Antibody Technologies; Sensor Technology; Clinical Chemistry; Other Technologies
3) By End-User: Hospitals; Clinical Laboratories; Diagnostic Centers; Other End-Users

Subsegments:
1) By Estradiol (E2) Test: Serum Estradiol Test; Urinary Estradiol Test
2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test; FSH Urine Test
3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test; Qualitative hCG Test
4) By Luteinizing Hormone (LH) Test: LH Serum Test; LH Urine Test
5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test; Saliva DHEAS Test
6) By Progesterone Test: Serum Progesterone Test; Urinary Progesterone Test
7) By Testosterone Test: Free Testosterone Test; Total Testosterone Test
8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test; TSH Saliva Test
9) By Prolactin Test: Serum Prolactin Test; Plasma Prolactin Test
10) By Other Types: Cortisol Test; Insulin Test; Growth Hormone (GH) Test; Aldosterone Test

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15562&type=smp

Who Are the Global Leaders in the Endocrine Testing Market?
Major companies operating in the endocrine testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Holding, Siemens Healthineers, Quest Diagnostics, Agilent Technologies Inc., PerkinElmer Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Qiagen N.V., Ortho Clinical Diagnostics, Kronus Inc., Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Inova Diagnostics Inc., Sekisui Diagnostics LLC, Mercodia AB, ZEUS Scientific Inc., IBL International, Monobind Inc., Agilus Diagnostics, Tosoh Bioscience Inc., DiaSorin S.p.A.

Which are the Top Profitable Regional Markets for the Endocrine Testing Industry?
North America was the largest region in the endocrine testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15562

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.